Clinical and laboratory changes from baseline in patients with or without anti-CCP antibodies after 6 months’ MTX treatment
| Change from baseline | Anti-CCP positive (n = 14) | Anti-CCP negative (n = 6) |
|---|---|---|
| None of the differences were significant. | ||
| ACR <20%, No (%) | 3 (21) | 1 (17) |
| ACR 20%, No (%) | 9 (64) | 2 (33) |
| ACR 50%, No (%) | 1 (7) | 1 (17) |
| ACR 70%, No (%) | 1 (7) | 2 (33) |
| CRP (mg/l) | 0 (0–6) | 15 (0–24) |
| ESR (mm/1st h) | 16 (7–30) | 23 (4–25) |
| IgM RF (BI) | 0.7 (0.4–1.7) | 0.3 (0–1.8) |